Company: NHICW
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001213900-25-076495
Chunk: 25

Company: NewHold Investment Corp. III
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 25
---
 8 — Shareholders’
Deficit

Preference Shares 

The Company is authorized to issue a total of
1,000,000 preference shares at par value of $0.0001 each after a share recapitalization in October 2024 that reduced authorize shares
from 5,000,000 shares. At June 30, 2025, there were no preferred shares issued or outstanding.

Class A Ordinary Shares 

The Company is authorized to issue a total of
479,000,000 Class A ordinary shares at par value of $0.0001 each after a share recapitalization in October 2024 that reduced authorized
shares from 500,000,000 shares. At June 30, 2025, there were 780,100 Class A ordinary shares issued and outstanding, excluding 20,125,000
shares that are subject to possible redemption.

Class B Ordinary Shares 

The Company is authorized to issue a total of
20,000,000 Class B ordinary shares at par value of $0.0001 each after a share recapitalization in October 2024 that reduced authorized
shares from 500,000,000 shares. In September 2024, the Company issued an aggregate of 5,031,250 Class B ordinary shares, $0.0001
par value, in exchange for a $25,000 payment (approximately $0.005 per share) from the Sponsor to cover certain expenses on behalf of
the Company. The Founder Shares included an aggregate of up to 656,250 shares subject to forfeiture if the over-allotment option is not
exercised by the underwriters in full.

In October 2024, the Company executed a share
recapitalization in which an additional 1,676,413 fully paid Class B ordinary shares were issued to the Sponsor, and as a result
of which the Sponsor has purchased and holds an aggregate of 6,707,663 Class B ordinary shares. Following and as a result of that
capitalization and issuance of Founder Shares, the Sponsor is deemed to have purchased the Founder Shares for $0.004 per share. Up to
874,912 of the Founder Shares could have been surrendered by the Sponsor for no consideration depending on the extent to which the underwriters’
over-allotment is exercised. Since the underwriters exercised their overallotment option in full, no Founder Shares have been or
will be